March 2026
The global cancer biologics market size is calculated at USD 117.45 billion in 2025 and is predicted to increase from USD 126.02 billion in 2026 to approximately USD 235.81 billion by 2035, expanding at a CAGR of 7.22% from 2026 to 2035.
March 2026
The global orthobiologics market size is calculated at USD 7.37 billion in 2025 and is predicted to increase from USD 7.78 billion in 2026 to approximately USD 12.55 billion by 2035, expanding at a CAGR of 5.47% from 2026 to 2035.
March 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 610.41 billion in 2025, with a CAGR of 14.80%.
February 2026
The global biologics CDMO market size was calculated at USD 23.08 billion in 2025 and is predicted to increase from USD 25.08 billion in 2026 to approximately USD 55.11 billion by 2035, expanding at a CAGR of 9.14% from 2026 to 2035.
January 2026
The global biologics market was valued at USD 487 billion in 2025 and is expected to hit around USD 1243.80 billion by 2035, growing at a CAGR of 9.83%.
October 2025
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
September 2025
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
August 2025
July 2025
The anti-Inflammatory biologics market size reached USD 104.81 billion in 2024 and is projected to surpass around USD 185.51 billion by 2034 with a notable CAGR of 5.88%.
July 2025
The global next-generation biologics market size was evaluated at USD 110.58 billion in 2024 and is predicted to hit around USD 301.22 billion by 2034, growing at a CAGR of 10.54% from 2025 to 2034.
June 2025
The global wound care biologics market size accounted for USD 5.84 billion in 2024 and is predicted to increase from USD 6.23 billion in 2025 to approximately USD 11.22 billion by 2034, expanding at a CAGR of 6.75% from 2025 to 2034.
April 2026
The global electrophoresis reagents market size was evaluated at USD 1.80 billion in 2025 and is predicted to hit around USD 3.44 billion by 2035, growing at a CAGR of 6.70%.
April 2026
The global hip reconstruction devices market size was evaluated at USD 9.30 billion in 2025 and is predicted to hit around USD 17.29 billion by 2035, growing at a CAGR of 6.40%.
April 2026
The global automation, digitization and robotics in cell and gene therapy manufacturing market size was evaluated at USD 950.00 million in 2025 and is predicted to hit around USD 5,275.10 million by 2035, growing at a CAGR of 18.70%.
April 2026
The global B-cell maturation antigen (BCMA) targeted therapies market size was evaluated at USD 5.60 billion in 2025 and is predicted to hit around USD 29.81 billion by 2035, growing at a CAGR of 18.20%.
April 2026
The global lab consumables market size is estimated to hit around USD 40.70 billion by 2035 increasing from USD 17.43 billion in 2025, with a CAGR of 8.85%.
April 2026
The global next-generation sequencing technologies market size is estimated to hit around USD 48.76 billion by 2035 increasing from USD 12.00 billion in 2025, with a CAGR of 15.05%.
April 2026
The global HIV diagnostics market size was evaluated at USD 1.34 billion in 2025 and is predicted to hit around USD 2.24 billion by 2035, growing at a CAGR of 5.26%.
April 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 3.20 billion in 2025, with a CAGR of 27.55%.
April 2026
The global hydroxychloroquine market size is estimated to hit around USD 2,885.89 million by 2035 increasing from USD 264.18 million in 2025, with a CAGR of 27.01%.
April 2026
The china medical devices market size is estimated to hit around USD 84.66 billion by 2035 increasing from USD 47.52 billion in 2025, with a CAGR of 5.94%.
April 2026
The global breast ultrasound market size was estimated at USD 2.62 billion in 2025 and is predicted to reach around USD 9.66 billion by 2035, with a CAGR of 13.94%.
April 2026
April 2026
The global joint reconstruction devices market size was estimated at USD 30.15 billion in 2025 and is predicted to increase from USD 31.49 billion in 2026 to approximately USD 46.31 billion by 2035, expanding at a CAGR of 4.39% from 2026 to 2035.
April 2026
The global alpha emitter market size is calculated at USD 696.72 billion in 2025 and is predicted to increase from USD 763.60 billion in 2026 to approximately USD 1,753.40 billion by 2035, expanding at a CAGR of 9.67% from 2026 to 2035.
April 2026
The global genitourinary drugs market size accounted at USD 30.04 billion in 2025 and is expected to be worth around USD 33.51 billion by 2035, at a CAGR of 1.10% from 2026 to 2035. The North America genitourinary drugs market size reached USD 14.56 billion in 2025.
April 2026
The global AI in life science analytics market size accounted at USD 2.46 billion in 2025 and is expected to be worth around USD 6.86 billion by 2035, at a CAGR of 10.80% from 2026 to 2035.
April 2026
The global human osteoblasts market size was evaluated at USD 51.86 million in 2025 and is projected to reach around USD 95.96 million by 2035, with a CAGR of 6.35%.
April 2026
The global inflammatory disease market size was evaluated at USD 125.00 billion in 2025 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
April 2026
The global endourology instruments and consumables market size was evaluated at USD 1.45 billion in 2025 and is predicted to hit around USD 3.10 billion by 2035, growing at a CAGR of 7.90%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com